ONS did not improve survival or rates of irAEs in metastatic patients receiving ICIs, whereas nutritional scores provided strong prognostic stratification. Prospective trials integrating longitudinal nutrition monitoring, immunonutrition, and multimodal cachexia therapy are warranted.
Acar et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: